Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0115 | 0.9357 | 1 |
Loa Loa (eye worm) | pyridoxal-dependent decarboxylase | 0.006 | 0.387 | 0.0767 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.006 | 0.387 | 1 |
Entamoeba histolytica | ornithine decarboxylase, putative | 0.006 | 0.387 | 0.5 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.006 | 0.387 | 1 |
Trichomonas vaginalis | ornithine decarboxylase, putative | 0.006 | 0.387 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0115 | 0.9357 | 1 |
Mycobacterium leprae | PROBABLE DIAMINOPIMELATE DECARBOXYLASE LYSA (DAP DECARBOXYLASE) | 0.0023 | 0.0173 | 0.5 |
Trichomonas vaginalis | diaminopimelate decarboxylase, putative | 0.006 | 0.387 | 1 |
Onchocerca volvulus | 0.006 | 0.387 | 0.5 | |
Plasmodium falciparum | S-adenosylmethionine decarboxylase/ornithine decarboxylase | 0.006 | 0.387 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.0081 | 0.5894 | 0.4226 |
Brugia malayi | Pyridoxal-dependent decarboxylase, pyridoxal binding domain containing protein | 0.006 | 0.387 | 0.0767 |
Trypanosoma brucei | ornithine decarboxylase | 0.006 | 0.387 | 0.5 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0115 | 0.9357 | 1 |
Trichomonas vaginalis | pyridoxal-dependent decarboxylase, putative | 0.006 | 0.387 | 1 |
Toxoplasma gondii | diaminopimelate decarboxylase | 0.006 | 0.387 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0173 | 0.0446 |
Leishmania major | ornithine decarboxylase, putative | 0.006 | 0.387 | 0.5 |
Giardia lamblia | Ornithine decarboxylase | 0.006 | 0.387 | 0.5 |
Mycobacterium tuberculosis | Diaminopimelate decarboxylase LysA (DAP decarboxylase) | 0.006 | 0.387 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 1 | 1 |
Plasmodium vivax | S-adenosylmethionine decarboxylase-ornithine decarboxylase, putative | 0.006 | 0.387 | 0.5 |
Mycobacterium ulcerans | diaminopimelate decarboxylase LysA | 0.006 | 0.387 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.8913 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.